ANTI-CYTOKERATIN 19
ANTI-CYTOKERATIN 19 Basic information
- Product Name:
- ANTI-CYTOKERATIN 19
- Synonyms:
-
- CYTOKERATIN 19 (AB-1) MONOCLONAL ANTIBODY
- ANTI-HUMAN CYTOKERATIN 19
- ANTI-HUMAN CYTOKERATIN 19 (40 KD)
- ANTI-CYTOKERATIN 19
- ANTI-CYTOKERATIN 19 (AB-1)
- ANTI-CYTOKERATIN 19, HUMAN
- ANTI-CYTOKERATIN 19, HUMAN (40KD)
- ANTI-CYTOKERATIN 19 MOUSE MAB
- MW:
- 0
- Mol File:
- Mol File
ANTI-CYTOKERATIN 19 Chemical Properties
- storage temp.
- −20°C
- biological source
- mouse
MSDS
- Language:English Provider:SigmaAldrich
ANTI-CYTOKERATIN 19 Usage And Synthesis
Uses
Monoclonal Anti-Cytokeratin Peptide 19 antibody produced in mouse is also suitable:
- for immunoblotting, for immunocytochemistry,
- for immunofluorescence,
- as a marker of premalignant lesions of the oral epithelium, to label cytokeratin in formalin-fixed or Carnoy-fixed, paraffin embedded tissue and in frozen sections of human tissue, to label simple epithelia and basal cells of noncornifying stratified squamous epithelia.
', 'Monoclonal Anti-Cytokeratin Peptide 19 antibody produced in mouse is suitable for microarray and indirect immunofluorescence at a dilution of 1:50 using formalin-fixed, paraffin-embedded and human tissue sections.
Biological Activity
Keratin, type I cytoskeletal 19 (40kDa protein) is also known as cytokeratin-19 (CK-19) or keratin-19 (K19). It is encoded by the KRT19 gene in humans. Keratin 19 is a type I keratin. Keratins are intermediate filament-forming proteins th at provide mechanical support and perform a variety of additional functions in epithelial cells. K19 is expressed in a subset of hepatocellular carcinomas (HCC) with poor prognosis and is considered as a biliary/hepatic progenitor cell (HPC) marker. It is also a predictor of poorer prognosis for patients with human lung squamous cell carcinoma (SCC).', 'Monoclonal anti-cytokeratins are specific markers of epithelial cell differentiation and have been widely used as tools in tumor identification and classification.